ClinVar Miner

Submissions for variant NM_000094.4(COL7A1):c.6110G>A (p.Gly2037Glu)

dbSNP: rs121912846
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000413679 SCV000490498 pathogenic not provided 2016-03-02 criteria provided, single submitter clinical testing The p.G2037E pathogenic variant in the COL7A1 gene has been reported previously (Jonkman et al., 1999, Sawamura et al., 2005, 2006, Almaani et al 2011). The p.G2037E variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The p.G2037E variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function as it occurs at the first Glycine position of the canonical Gly-X-Y repeat in the collagenous domain of the colVII protein. Glycine substitution variants in this region of the collagen VII protein will destabilize the collagen triple helix resulting in anchoring fibrils that are fragile and result in poor anchoring off the basement membrane to the underlying dermis. Missense variants in nearby residues (G2034R, E, W, V, G2040S, V, D) have been reported in the Human Gene Mutation Database in association with DEB (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret p.G2037E as a pathogenic variant.
Center for Research in Genodermatoses and Epidermolysis Bullosa, University of Buenos Aires RCV000019004 SCV002499386 pathogenic Generalized dominant dystrophic epidermolysis bullosa 2022-03-14 criteria provided, single submitter clinical testing
OMIM RCV000019004 SCV000039291 pathogenic Generalized dominant dystrophic epidermolysis bullosa 2006-01-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.